Jack A. Roth
1,198 works · 57,673 citations · h-index 117
Top works
- Somatic mutations affect key pathways in lung adenocarcinoma
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
- BRAF and RAS mutations in human lung cancer and melanoma.
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer
- Characterizing the cancer genome in lung adenocarcinoma
- Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus
- Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
- Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
- Survival in early-stage non-small cell lung cancer
- Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer
- Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
- Focus on lung cancer
- Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
- Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
- Long-Term Results of RTOG Trial 8911 (USA Intergroup 113): A Random Assignment Trial Comparison of Chemotherapy Followed by Surgery Compared With Surgery Alone for Esophageal Cancer
- Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.
- Gene Therapy for Cancer: What Have We Done and Where Are We Going?
- Determinants of perioperative morbidity and mortality after pneumonectomy
- Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.